(1) Analysis of the whole sample regarding the frequency of limiting treatment as one aspect of end-of-life practices (n = 403) |
(2) Analysis of the subgroup concerning “Types of limited treatment and expected consequences” (n = 104) |
(3) Analysis of the subgroup “Decision-making and patient involvement” (n = 81) |
(4) Regression analysis on determinants associated with limitation of treatment and expected shortening of life (n = 403) |